CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 133 enrolled
Drug / intervention
Heart Valve Surgeryprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01651052
NCT01651052N/ACompleted

Clinical Trial of the Edwards Aortic Bioprosthesis, Model 11000

Edwards Lifesciences·interventional·Posted Jul 26, 2012·Updated Jul 26, 2019

In Brief

A clinical study evaluating Heart Valve Surgery for Aortic Valve Disorder and 4 related conditions. Completed, enrolled 133 participants across 2 sites.

Detailed Summary

The purpose of this observational trial is to gather further clinical data to confirm the safety and performance of the Edwards Pericardial Aortic Bioprosthesis, Model 11000 in this trial population.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesPoland
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJul 26, 2012
Enrollment StartJul 1, 2011
Primary CompletionJul 1, 2018
TodayJul 2, 2026
Enrollment to primary: 7 yearsPosted 13.9 years ago

Interventions

Heart Valve Surgeryprocedure

Implant of an aortic valve, Model 11000